• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可充电脂质衍生物:一种新型 pH 响应脂质,用于纳米颗粒介导的 siRNA 递药。

Charge-reversible lipid derivative: A novel type of pH-responsive lipid for nanoparticle-mediated siRNA delivery.

机构信息

Department of Medical Biochemistry, University of Shizuoka, School of Pharmaceutical Sciences, 52-1 Yada, Suruga-ku, Shizuoka 422-8526, Japan.

Nippon Fine Chemical Co. Ltd., 5-1-1 Umei, Takasago, Hyogo 676-0074, Japan.

出版信息

Int J Pharm. 2020 Jul 30;585:119479. doi: 10.1016/j.ijpharm.2020.119479. Epub 2020 May 27.

DOI:10.1016/j.ijpharm.2020.119479
PMID:32473372
Abstract

RNA interference induced by small interfering RNA (siRNA) is a promising strategy for the treatment of various intractable diseases including cancer. Lipid nanoparticles (LNP) composed of ionizable lipids and siRNA are known as a leading siRNA delivery system. However, LNPs composed of conventional ionizable lipids will be aggregated in the physiological environment because of loss of ionization. Therefore, the inclusion of hydrophilic polymer-conjugated lipids such as polyethylene glycol (PEG)-conjugated lipid is required to improve the LNP stability. Herein, we synthesized a novel charge-reversible lipid derivative, dioleoylglycerophosphate-diethylenediamine conjugate (DOP-DEDA). The surface of LNP composed of DOP-DEDA (DOP-DEDA LNP) was constantly ionized and positively charged at pH 6.0, almost neutral at pH 7.4, and negatively charged at pH 8.0. Importantly, DOP-DEDA LNP were stable in the physiological milieu without PEG-conjugated lipid. DOP-DEDA LNP disrupted the red blood cells only under the low-pH condition in a hemolysis assay, suggesting that the interaction between DOP-DEDA LNP and biological membranes is pH-dependent. DOP-DEDA LNP encapsulating siRNA against polo-like kinase 1 (siPLK1) highly suppressed the expression of PLK1 mRNA and its protein. The cellular uptake of DOP-DEDA LNP was increased in an apolipoprotein E3 (apoE3) dose-dependent manner. In addition, DOP-DEDA LNP was taken up into cancer cells via both clathrin- and caveola-mediated endocytosis pathways. These findings indicate that LNP composed of this charge-reversible lipid should be a highly stable and potent siRNA delivery vector.

摘要

小干扰 RNA(siRNA)诱导的 RNA 干扰是治疗各种难治性疾病(包括癌症)的一种有前途的策略。由可离子化脂质和 siRNA 组成的脂质纳米颗粒(LNP)被认为是一种领先的 siRNA 递送系统。然而,由于失去电离,由常规可离子化脂质组成的 LNPs 在生理环境中会聚集。因此,需要包含亲水性聚合物缀合脂质(如聚乙二醇(PEG)缀合脂质)来提高 LNP 的稳定性。在此,我们合成了一种新型电荷可逆脂质衍生物,二油酰基甘油磷酸二乙二胺缀合物(DOP-DEDA)。由 DOP-DEDA 组成的 LNP(DOP-DEDA LNP)的表面在 pH 6.0 时不断电离并带正电荷,在 pH 7.4 时几乎呈中性,在 pH 8.0 时带负电荷。重要的是,DOP-DEDA LNP 在没有 PEG 缀合脂质的生理环境中是稳定的。在溶血试验中,DOP-DEDA LNP 仅在低 pH 条件下破坏红细胞,表明 DOP-DEDA LNP 与生物膜的相互作用是 pH 依赖性的。包封针对 Polo 样激酶 1(siPLK1)的 siRNA 的 DOP-DEDA LNP 高度抑制了 PLK1 mRNA 和其蛋白的表达。DOP-DEDA LNP 的细胞摄取呈载脂蛋白 E3(apoE3)剂量依赖性增加。此外,DOP-DEDA LNP 通过网格蛋白和小窝蛋白介导的内吞途径被摄取到癌细胞中。这些发现表明,由这种电荷可逆脂质组成的 LNP 应该是一种高度稳定和有效的 siRNA 递送载体。

相似文献

1
Charge-reversible lipid derivative: A novel type of pH-responsive lipid for nanoparticle-mediated siRNA delivery.可充电脂质衍生物:一种新型 pH 响应脂质,用于纳米颗粒介导的 siRNA 递药。
Int J Pharm. 2020 Jul 30;585:119479. doi: 10.1016/j.ijpharm.2020.119479. Epub 2020 May 27.
2
Increasing the siRNA knockdown efficiency of lipid nanoparticles by morphological transformation with the use of dihydrosphingomyelin as a helper lipid.通过使用二氢神经鞘氨醇作为辅助脂质进行形态转化来提高脂质纳米粒的 siRNA 敲低效率。
Biomater Sci. 2023 May 2;11(9):3269-3277. doi: 10.1039/d3bm00068k.
3
Cytosolic protein delivery using pH-responsive, charge-reversible lipid nanoparticles.利用 pH 响应、电荷可逆脂质纳米粒进行细胞质蛋白递送。
Sci Rep. 2021 Oct 6;11(1):19896. doi: 10.1038/s41598-021-99180-5.
4
On the Formation and Morphology of Lipid Nanoparticles Containing Ionizable Cationic Lipids and siRNA.含可离子化阳离子脂质体和 siRNA 的脂质纳米粒的形成和形态。
ACS Nano. 2018 May 22;12(5):4787-4795. doi: 10.1021/acsnano.8b01516. Epub 2018 Apr 6.
5
Lipid Nanoparticle Formulations for Enhanced Co-delivery of siRNA and mRNA.用于增强 siRNA 和 mRNA 共递送的脂质纳米颗粒制剂。
Nano Lett. 2018 Jun 13;18(6):3814-3822. doi: 10.1021/acs.nanolett.8b01101. Epub 2018 May 8.
6
Influence of particle size on the in vivo potency of lipid nanoparticle formulations of siRNA.粒径对 siRNA 脂质纳米粒制剂体内效力的影响。
J Control Release. 2016 Aug 10;235:236-244. doi: 10.1016/j.jconrel.2016.05.059. Epub 2016 May 26.
7
pH-labile PEGylation of siRNA-loaded lipid nanoparticle improves active targeting and gene silencing activity in hepatocytes.载有 siRNA 的脂质纳米粒的 pH 敏感性聚乙二醇化可改善其在肝细胞中的主动靶向和基因沉默活性。
J Control Release. 2017 Sep 28;262:239-246. doi: 10.1016/j.jconrel.2017.07.046. Epub 2017 Aug 1.
8
Systemic Administration of siRNA with Anti-HB-EGF Antibody-Modified Lipid Nanoparticles for the Treatment of Triple-Negative Breast Cancer.载反 HB-EGF 抗体修饰的脂质纳米粒的 siRNA 系统给药治疗三阴性乳腺癌。
Mol Pharm. 2018 Apr 2;15(4):1495-1504. doi: 10.1021/acs.molpharmaceut.7b01055. Epub 2018 Mar 12.
9
Small molecule ligands for enhanced intracellular delivery of lipid nanoparticle formulations of siRNA.小分子配体增强 siRNA 脂质纳米粒制剂的细胞内递送。
Nanomedicine. 2013 Jul;9(5):665-74. doi: 10.1016/j.nano.2012.11.006. Epub 2012 Dec 6.
10
Improved Stability of siRNA-Loaded Lipid Nanoparticles Prepared with a PEG-Monoacyl Fatty Acid Facilitates Ligand-Mediated siRNA Delivery.用聚乙二醇单酯脂肪酸制备的负载 siRNA 的脂质纳米粒稳定性提高,有助于配体介导的 siRNA 递释。
Mol Pharm. 2020 Apr 6;17(4):1397-1404. doi: 10.1021/acs.molpharmaceut.0c00087. Epub 2020 Mar 2.

引用本文的文献

1
Hydrogen-induced disruption of the airway mucus barrier enhances nebulized RNA delivery to reverse pulmonary fibrosis.氢气诱导的气道黏液屏障破坏增强雾化RNA递送以逆转肺纤维化。
Sci Adv. 2025 Apr 18;11(16):eadt2752. doi: 10.1126/sciadv.adt2752. Epub 2025 Apr 16.
2
Advances in Cytosolic Delivery of Proteins: Approaches, Challenges, and Emerging Technologies.蛋白质胞质递送的进展:方法、挑战与新兴技术
Chem Biodivers. 2025 Jun;22(6):e202401713. doi: 10.1002/cbdv.202401713. Epub 2025 Feb 17.
3
Navigating the intricate in-vivo journey of lipid nanoparticles tailored for the targeted delivery of RNA therapeutics: a quality-by-design approach.
针对 RNA 治疗药物靶向递送而设计的脂质纳米粒的体内复杂旅程的探索:一种基于质量设计的方法。
J Nanobiotechnology. 2024 Nov 14;22(1):710. doi: 10.1186/s12951-024-02972-w.
4
Chemistry and Art of Developing Lipid Nanoparticles for Biologics Delivery: Focus on Development and Scale-Up.用于生物制品递送的脂质纳米颗粒的化学与研发工艺:聚焦于研发与放大生产
Pharmaceutics. 2024 Jan 19;16(1):131. doi: 10.3390/pharmaceutics16010131.
5
Delivery of nucleic acids using nanomaterials.使用纳米材料递送核酸。
Mol Biomed. 2023 Dec 14;4(1):48. doi: 10.1186/s43556-023-00160-0.
6
Ionizable drug delivery systems for efficient and selective gene therapy.用于高效和选择性基因治疗的可离子化药物传递系统。
Mil Med Res. 2023 Feb 27;10(1):9. doi: 10.1186/s40779-023-00445-z.
7
Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery.采用多种技术方法制备具有组织特异性的 mRNA 递药的选择性器官靶向(SORT)脂质纳米粒(LNPs)。
Nat Protoc. 2023 Jan;18(1):265-291. doi: 10.1038/s41596-022-00755-x. Epub 2022 Oct 31.
8
Broadening the Horizons of RNA Delivery Strategies in Cancer Therapy.拓展癌症治疗中RNA递送策略的视野
Bioengineering (Basel). 2022 Oct 19;9(10):576. doi: 10.3390/bioengineering9100576.
9
Phenylboronic Acid-Modified Polyamidoamine Mediated the Transfection of Polo-Like Kinase-1 siRNA to Achieve an Anti-Tumor Efficacy.苯硼酸修饰的聚酰胺-胺介导 Polo 样激酶-1 siRNA 的转染以实现抗肿瘤功效。
Int J Nanomedicine. 2021 Dec 13;16:8037-8048. doi: 10.2147/IJN.S329433. eCollection 2021.
10
Cytosolic protein delivery using pH-responsive, charge-reversible lipid nanoparticles.利用 pH 响应、电荷可逆脂质纳米粒进行细胞质蛋白递送。
Sci Rep. 2021 Oct 6;11(1):19896. doi: 10.1038/s41598-021-99180-5.